5 Best Biotech Stocks Under $10

Page 5 of 5

1. Amarin Corporation plc (NASDAQ: AMRN)

Number of Hedge Fund Holders: 21

Amarin Corporation plc (NASDAQ: AMRN) tops our list of the best biotech stocks under $10. It is a rapidly growing, innovative biotech company that focuses on developing and commercializing cost-effective therapies to improve patients’ health. The company’s lead product, VASCEPA, is made to address cardiovascular risk for patients globally.

Recently, SVB Leerink initiated its coverage on Amarin Corporation plc (NASDAQ: AMRN), with an ‘Outperform’ rating and a $12 price target. The firm’s analyst believes that the company’s VASCEPA will help achieve improved cardiovascular risk outcomes. In Q2 2021, Amarin Corporation plc (NASDAQ: AMRN) posted an EPS of $0.03, beating the consensus by $0.06. The consolidated revenue presented a 14.2% year-over-year growth at $154.4 million. The company plans to launch VASCEPA in Europe (as VAZKEPA) this September, starting from Germany. Currently traded at $5.30, Amarin Corporation plc (NASDAQ: AMRN) gained 29.9% in the last year.

As of Q2 2021, 21 hedge funds tracked by Insider Monkey have positions in Amarin Corporation plc (NASDAQ: AMRN), worth $298.4 million. In the previous quarter, 21 hedge funds held stakes in the company, worth $444.2 million.

You can also take a look at 10 Best Small-Cap Biotech Stocks Under $10 in 2021 and 15 Fastest Growing Biotech Companies in the US

Page 5 of 5